title: Levels of biological markers of nitric oxide in serum of patients with squamous cell carcinoma of the oral cavity.
abstract: The aim of the study was a determination of the levels of nitric oxide (NO) and its biological markers such as malonyldialdehyde (MDA) and nitrotyrosine in the serum of patients with squamous cell carcinoma (SCC) of the oral cavity and identification of the relationships between NO and those markers. These studies were performed on patients with SCC of the oral cavity before and after treatment. Griess reaction was used for the estimation of the total concentration of NO in serum. The nitrotyrosine level in serum was assessed with an enzyme-linked immunosorbent assay (ELISA) kit, and MDA level using a spectrophotometric assay. Higher concentrations of NO in blood serum were determined in patients with stage IV of the disease before treatment in comparison to the control group and patients with stages II and III of the disease. Moreover, higher concentrations of MDA and nitrotyrosine were determined in the serum of patients in all stages of the disease in comparison to healthy people. After treatment, lower concentrations of NO in the serum of patients with stage IV of the disease were observed in comparison to the amounts obtained prior to treatment. In addition, lower levels of nitrotyrosine in the serum of patients with all stages of the disease were recorded, whereas higher concentrations of MDA were determined in these patients in comparison to results obtained before treatment. The compounds formed with the contribution of NO, such as MDA and nitrotyrosine, may lead to cancer progression in patients with SCC of the oral cavity, and contribute to formation of resistance to therapy in these patients as well. Moreover, the lack of a relationship between concentrations of NO and MDA, and between NO and nitrotyrosine in serum suggests that the process of lipid peroxidation and nitration in patients with SCC does not just depend on NO.
authors: Department of Immunology, Medical University of Bialystok, Bialystok, Poland.
authors: Wioletta
authors: W
authors: Ratajczak-Wrona
authors: Ewa
authors: E
authors: Jablonska
authors: Bozena
authors: B
authors: Antonowicz
authors: Dorota
authors: D
authors: Dziemianczyk
authors: Stanislawa Zyta
authors: SZ
authors: Grabowska
mesh_terms: D000368:Aged; D002294:Carcinoma, Squamous Cell / Q000097:blood* / Q000378:metabolism; D016022:Case-Control Studies; D005260:Female; D006801:Humans; D015227:Lipid Peroxidation; D008297:Male; D008315:Malondialdehyde / Q000097:blood*; D009062:Mouth Neoplasms / Q000097:blood* / Q000378:metabolism; D009569:Nitric Oxide / Q000097:blood*; D018709:Statistics, Nonparametric; D014443:Tyrosine / Q000031:analogs & derivatives* / Q000097:blood
chemical_list: D009569:Nitric Oxide; C002744:3-nitrotyrosine; D014443:Tyrosine; D008315:Malondialdehyde
references: Chem Res Toxicol. 1993 Jan-Feb;6(1):2-18
references: 8448344
references: Am J Physiol. 1998 Jul;275(1):C1-24
references: 9688830
references: Int J Oncol. 1998 Oct;13(4):699-704
references: 9735398
references: Free Radic Biol Med. 1998 Sep;25(4-5):434-56
references: 9741580
references: Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006 Jul;102(1):67-76
references: 16831675
references: Am J Physiol. 1996 Jan;270(1 Pt 2):H411-5
references: 8769777
references: J Oral Pathol Med. 1999 Sep;28(8):355-9
references: 10478960
references: Int J Radiat Oncol Biol Phys. 2002 Aug 1;53(5):1192-202
references: 12128120
references: Oral Oncol. 2007 Apr;43(4):333-8
references: 16857409
references: BMB Rep. 2008 Mar 31;41(3):194-203
references: 18377722
references: J Clin Pharm Ther. 1995 Oct;20(5):259-63
references: 8576292
references: J Natl Cancer Inst. 1998 Apr 15;90(8):587-96
references: 9554441
references: FASEB J. 1995 Oct;9(13):1319-30
references: 7557022
references: Cancer Res. 1997 Aug 1;57(15):3300-4
references: 9242464
references: FASEB J. 1997 May;11(6):443-8
references: 9194524
references: Head Neck. 1999 Oct;21(7):627-38
references: 10487950
references: Neoplasma. 2006;53(3):200-5
references: 16652188
references: Jpn J Cancer Res. 1994 Apr;85(4):331-4
references: 7515384
references: Biochim Biophys Acta. 1999 May 5;1411(2-3):263-72
references: 10320662
references: Jpn J Clin Oncol. 2004 Jul;34(7):379-85
references: 15342664
references: J Oral Maxillofac Surg. 2002 Aug;60(8):905-10; discussion 910-1
references: 12149736
references: Arch Oral Biol. 2003 Feb;48(2):93-100
references: 12642227
references: Oral Oncol. 1999 May;35(3):273-7
references: 10621847
references: Cell Res. 2002 Dec;12(5-6):311-20
references: 12528889
references: Arch Biochem Biophys. 1999 Jan 15;361(2):252-6
references: 9882453
references: Anticancer Res. 1997 Mar-Apr;17(2A):865-71
references: 9137419
references: Oral Oncol. 2005 Mar;41(3):261-7
references: 15743688
references: Wiad Lek. 2007;60(1-2):4-9
references: 17607961
references: Nature. 2008 Jul 24;454(7203):436-44
references: 18650914
references: Postepy Hig Med Dosw (Online). 2005 Mar 17;59:75-81
references: 15928590
references: Oncologist. 2004;9 Suppl 5:10-7
references: 15591418
references: Toxicology. 2000 Aug 7;148(2-3):93-101
references: 10962127
references: Blood. 2001 Feb 15;97(4):1009-15
references: 11159530
references: Oncology. 2011;80(5-6):382-9
references: 21829039
references: Med Sci Monit. 2001 Jul-Aug;7(4):801-19
references: 11433215
references: Dis Mon. 2001 Jul;47(7):275-361
references: 11477373
references: Cancer Chemother Pharmacol. 2011 Jun;67(6):1211-24
references: 21544630
references: Adv Med Sci. 2007;52:154-8
references: 18217409
references: Oral Dis. 2010 Jan;16(1):29-33
references: 19656315
references: Laryngoscope. 1999 Jan;109(1):148-52
references: 9917057